Company / Cash & Equivalents
American Well Corp Cash & Equivalents History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$182.3M
FY2025
5-year range
$182.3M / $941.6M
FY2021-FY2025
Trend
-20.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 4 consecutive years, from $942M in FY2021 to $182M in FY2025.
Based on SEC 10-K filings.
$182M in FY2025 with a 5-year CAGR of +5.8%.
Declined from $372M to $182M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -37.5%
- 5-Year CAGR
- +5.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- American Well Corp's cash & equivalents has declined for 4 consecutive years.
- 5-year CAGR of +5.8%, indicating consistent growth.
- In FY2025, cash & equivalents decreased 20.1% year-over-year.
- Peak cash & equivalents was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -4.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $182.3M | -20.1% |
| FY2024 | $228.3M | -38.6% |
| FY2023 | $372.0M | -50.2% |
| FY2022 | $746.4M | -20.7% |
| FY2021 | $941.6M | +584.0% |
| FY2020 | $137.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026